Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.509NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.293NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.637NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.26 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.103 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
LF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.75 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.100 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.44 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used